![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/7-Figure5-1.png "PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar")
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
IJMS | Free Full-Text | Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization | HTML
PTC-209 reduces BMI-1 levels, PRC1 activity, and inhibits cell growth... | Download Scientific Diagram
PTC-209 reduced Bmi1 expression by transcriptional repression and... | Download Scientific Diagram
BMI-1 downregulation by PTC-209 leads to an increase in H3K27me3... | Download Scientific Diagram
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal
PTC-209 demonstrates on-target effects in MM via downregulation of... | Download Scientific Diagram
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
PTC-209 is a potent anti-myeloma agent that induces apoptosis. (A)... | Download Scientific Diagram
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. - Abstract - Europe PMC
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/2-Figure1-1.png "PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar")
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo | Scientific Reports
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
BMI-1 downregulation by PTC-209 affects stemness properties of DIPG.... | Download Scientific Diagram
PTC-209 | BMI-1 Inhibitor | MedChemExpress
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
